相关实验视频
Updated: Jun 13, 2025

08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.2K
矩阵格拉蛋白和氧化合成酶-3在慢性病中的遗传变异及其与心血管风险的关系
G Priyadarshini1, Sreejith Parameswaran2, Jayaprakash Sahoo3
1Department of Biochemistry Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
International journal of nephrology
|September 9, 2024
概括
矩阵格拉蛋白 (MGP) 和氧化合成-3 (NOS3) 基因中的遗传变异增加了南印度泰米尔人患慢性病 (CKD) 和相关心血管疾病的风险.
科学领域:
- 遗传学 是一个遗传学.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
背景情况:
- 慢性病 (CKD) 的特点是逐渐丧失功能.
- 慢性病显著增加心血管事件的风险,这种联系尚未完全理解.
- 内皮功能障碍是CKD与心血管疾病相关的关键因素.
研究的目的:
- 研究MGP和NOS3基因中的遗传变异与CKD风险之间的关联.
- 检查这些遗传变异对CKD患者心血管并发症的影响.
- 探索这些遗传变异,氧化 (NO) 水平和内皮功能之间的关系.
主要方法:
- 在185名CKD患者和185名对照中进行MGP (rs1800801, rs1800802, rs4236) 和NOS3 (rs1799983, rs2070744) 多态的基因定型.
- 使用ELISA测量循环中的氧化 (NO) 水平.
- 通过超声波评估手臂动脉流介导扩张 (FMD),以评估内皮功能.
主要成果:
- 特定的NOS3 (rs2070744) 和MGP多态的基因型与CKD风险增加有显著的关联.
- 与对照组相比,在CKD患者中观察到较低的NO水平.
- 某些MGP和NOS3基因型与口病的降低相关,表明内皮功能障碍.
结论:
- 在MGP和NOS3基因的遗传变异有助于患CKD的风险.
- 这些遗传因素似乎也增加了CKD患者心血管并发症的风险.
- 这项研究强调了遗传倾向在南印度泰米尔人群中CKD和心血管疾病之间的复杂相互作用中的作用.
相关概念视频
Glomerular Filtration Rate and its Regulation
2.4K
The Glomerular Filtration Rate (GFR) is a measure of kidney function, reflecting the volume of filtrate formed per minute in the kidneys. On average, GFR is approximately 125 mL/min in males and 105 mL/min in females. Maintaining a relatively constant GFR is essential for the kidneys to effectively regulate body fluid homeostasis and maintain extracellular stability.
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
2.4K
Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
64
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
64
Renal Corpuscle
1.7K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
1.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
398
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
398

